SO
FHTX icon

STRS Ohio’s Foghorn Therapeutics FHTX Stock Holding History

STRS Ohio’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$41.1K Hold
8,600
– – ﹤0.01% 1967
2025
Q4 		$46.4K Buy
8,600
+4,700
+121% +$21.3K ﹤0.01% 1994
2025
Q3 		$19.1K Buy
+3,900
New +$20.7K ﹤0.01% 2121
2021
Q1 		– Sell
-1,700
Closed -$34K – 2207
2020
Q4 		$34K Buy
+1,700
New +$32.6K ﹤0.01% 2032

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

STRS Ohio's FHTX Position: Q1 2026 in Review

STRS Ohio held its Foghorn Therapeutics (FHTX) position steady in Q1 2026 at 8,600 shares worth $41.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1967.

STRS Ohio first reported a position in FHTX in Q4 2020 and has held it in 4 quarters since. The position peaked at $46.4K in Q4 2025. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • STRS Ohio held 8,600 shares of Foghorn Therapeutics worth $41.1K as of Q1 2026.
  • STRS Ohio left its Foghorn Therapeutics share count unchanged in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #1967 holding.
  • STRS Ohio first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 4 quarters since.
  • STRS Ohio's Foghorn Therapeutics position peaked at $46.4K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.